EC report on activities to monitor medicine safety in EU

30 September 2016

The Commission has published a report on activities by Member States and the European Medicines Agency (EMA), to monitor the safety of medicines throughout their life cycle as foreseen by the 2010 amendment of the EU legislation from 2001 and 2004. The report describes the activities of the collaborative EU system for monitoring and controlling the safety of human medicines since the new legislation came into effect in 2012 until July 2015.
The report concludes that the European pharmacovigilance network is an example of successful cooperation at EU level which directly benefits patients. Work is underway on improving the system’s infrastructure (EU Public Health News, 8 August 2016).
Click here for the full news item.
Click here to download the report from the commission (376 kB).
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the NVC E-Course Pharmaceutical Packaging.

If you have any questions about this subject, please contact us: info@nvc.nl, +31-(0)182-512411. This item is also included in our monthly overview, the NVC Members-only Update.